ARTICLE | Company News
FDA approves Bausch & Lomb's Retisert
April 12, 2005 1:00 AM UTC
FDA granted marketing approval to BOL for its Retisert fluocinolone acetonide intravitreal implant to treat chronic non-infectious posterior uveitis. The synthetic steroid delivered using an implantab...